Financials in USD. Standardized financial statements.
A compact view of how Abiomed, Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.03B | $847.52M | $840.88M | $769.43M | $593.75M | $445.30M | $329.54M | $230.31M | $183.64M | $158.12M |
| Revenue Growth? | +21.7% | +0.8% | +9.3% | +29.6% | +33.3% | +35.1% | +43.1% | +25.4% | +16.1% | 0.0% |
| Cost of Revenue? | $188.16M | $161.91M | $151.31M | $129.57M | $98.58M | $70.63M | $50.42M | $39.95M | $37.32M | $31.60M |
| Gross Profit? | $843.60M | $685.62M | $689.58M | $639.87M | $495.17M | $374.68M | $279.12M | $190.37M | $146.32M | $126.53M |
| Gross Margin? | +81.8% | +80.9% | +82.0% | +83.2% | +83.4% | +84.1% | +84.7% | +82.7% | +79.7% | +80.0% |
| Operating Expenses? | $586.89M | $456.06M | $440.36M | $415.05M | $338.03M | $284.54M | $214.02M | $161.70M | $137.96M | $109.98M |
| Operating Income? | $372.69M | $229.56M | $249.22M | $224.81M | $157.14M | $90.14M | $65.10M | $28.67M | $8.36M | $16.54M |
| EBITDA? | $500.46M | $246.94M | $257.48M | $230.77M | $164.45M | $94.79M | $67.99M | $31.24M | $10.75M | $19.27M |
| Income Before Tax | $190.56M | $288.22M | $256.82M | $263.36M | $160.44M | $91.34M | $65.84M | $28.77M | $8.53M | $16.86M |
| Income Tax Expense | $54.05M | $62.70M | $53.82M | $4.34M | $48.27M | $39.23M | $27.69M | -$84.92M | $1.18M | $1.85M |
| Net Income? | $136.50M | $225.53M | $203.01M | $259.02M | $112.17M | $52.12M | $38.15M | $113.69M | $7.35M | $15.01M |
| EPS? | $3.00 | $5.00 | $4.49 | $5.77 | $2.54 | $1.21 | $0.90 | $2.80 | $0.19 | $0.38 |
| Diluted EPS? | $2.98 | $4.94 | $4.43 | $5.61 | $2.45 | $1.17 | $0.85 | $2.65 | $0.18 | $0.37 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality